Publication | Closed Access

The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden

ThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseHealth PolicyHealth EconomicsOutcomes ResearchPlatelet AntagonistPharmacotherapyPublic HealthLong-term Cost-effectivenessMedicineAnticoagulantAtherosclerosisCoronary Artery DiseaseAnesthesiology